Companies: 10,795·Total market cap: $144.5T
Exelixis, Inc.

Exelixis, Inc.

EXELNASDAQHealthcare● Active
$52.70
+$0.21(+0.40%)
Market Cap$13.2B
P/E Ratio
52W High$52.98
52W Low$33.76

Exelixis, Inc. (EXEL) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

exel · stock forecast · 32 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 32 Wall Street analysts in the past 3 months

SellBuy

Buy

32 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
16
Hold
16
Sell
0
Strong Sell
0
Total: 32 · Buy rate: 50.0%

12-Month Price Target

High

$54.00

Consensus

$47.33

-10.2% upside

Low

$41.00

Median: $47 · Last Close: $52.70

The Exelixis, Inc. (EXEL) analyst consensus is Buy, based on ratings from 32 Wall Street analysts over the past 3 months. The average 12-month EXEL price target is $47.33, representing -10.2% upside from the current price of $52.70.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $47 (-10.2%)

Consensus Target

$47.33

-10.2% upside

High Target

$54

2.5%

Low Target

$41

-22.2%

Current Price

$52.70

as of today

Based on analyst price targets, the EXEL stock price prediction for the next 12 months ranges from $41 to $54. The consensus EXEL price forecast of $47.33 implies -10.2% upside from the current price of $52.70.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$53.461.43%

1-day model range: $53.17–$53.74. Peak: $53.74 (+1.43%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$84+60.0%
2028$117+122.4%
2029$147+178.8%
2030$171+224.7%
2031+259.5%
Confidence:MediumCapped at 60% annual limit

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)60.6Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · EXEL · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$51.12BUY
MA 10$50.77BUY
MA 20$50.28BUY
MA 50$46.83BUY
MA 100$44.87BUY
MA 200$42.83BUY
Current $EXEL · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$51.62BUY
EMA 10$50.94BUY
EMA 20$49.90BUY
EMA 50$47.59BUY
EMA 100$45.68BUY
EMA 200$43.47BUY
Current $EXEL · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-05-07
Maintains
BuyBuy
Morgan Stanley2026-05-06
Maintains
Equal WeightEqual Weight
Wells Fargo2026-05-06
Maintains
Equal WeightEqual Weight
TD Cowen2026-05-06
Maintains
BuyBuy
Stifel2026-05-06
Maintains
HoldHold
Barclays2026-04-20
Maintains
Equal WeightEqual Weight
RBC Capital2026-03-02
Maintains
Sector PerformSector Perform
HC Wainwright & Co.2026-02-12
Maintains
BuyBuy
RBC Capital2026-02-11
Maintains
Sector PerformSector Perform
Stifel2026-02-11
Maintains
HoldHold

Wall Street analysts have recently issued updated ratings on Exelixis, Inc. (EXEL) stock. Of the recent 222 rating actions, 11 were upgrades and 18 were downgrades. 32 analysts currently cover EXEL.

Analyst Recommendation Trends

Buy ratings321
Hold ratings33
Sell ratings00

EXEL analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$2.6B

↓ 19.7% YoY

Revenue Next Year

$2.9B

↑ 12.4% YoY

EPS This Year

$3.52

EPS Next Year

$3.93

↑ 11.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast EXEL EPS of $3.52 for the current fiscal year, based on estimates from 11 analysts. The EXEL revenue forecast is $2.6B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The EXEL stock forecast is supported by two independent data sources: analyst consensus ratings from 32 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EXEL price target is $47.33 (-10.2% upside), with an analyst consensus of Buy.

The EXEL short-term stock prediction for tomorrow is $53.46 (+1.43%). The EXEL stock price prediction for 2027 estimates an average of $84. The EXEL stock prediction for 2030 projects a range of $161–$181.

Exelixis, Inc. trades on NASDAQ under the ticker EXEL. The EXEL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

EXEL forecast · 8 questions

According to 32 Wall Street analysts, the average 12-month EXEL price target is $47.33, with a high forecast of $54.00 and a low of $41.00. The median price target is shown in the chart above when available. This implies -10.2% potential upside from the current price of $52.70.

EXEL price targetWhat is EXEL price targetEXEL analyst price targetEXEL 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.